Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription 02.06.2025 1 Acta Haematol 2 Am J Clin Pathol 1 Am J Hematol 3 Ann Hematol 5 Blood 3 Bone Marrow Transplant 1 Cancer Lett 1 Eur J Haematol 3 Int J Hematol 2 Leukemia 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. DRAGOI OD, Shah M, Potter V, Avenoso D, et al
   Disseminated Mucormycosis and T-Cell-Depleted Allogeneic Stem Cell Transplantation: An Unusual Case Study.
   Acta Haematol. 2025;148:362-368.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

2. HASSAN F, Zhang H, Idiaquez DW, Pakasticali N, et al
   KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features.
   Am J Clin Pathol. 2025 May 26:aqaf041. doi: 10.1093.
   PubMed         Abstract available
   
   
3. RICHMAN LP, Waller BF, Lovitch SB, Jambhekar A, et al
   Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia varies with interpreter expertise and mutation status.
   Am J Clin Pathol. 2025 May 25:aqaf047. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Hematol

4. GANGAT N, Tefferi A
   CPX-351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on?
   Am J Hematol. 2025 May 29. doi: 10.1002/ajh.27730.
   PubMed         Abstract available
   
   

   
   Ann Hematol

5. SUN K, Shi ZY, Wang YZ, Xie DH, et al
   The expression patterns and prognostic significance of PD-1 and TIM-3 on T cells and the differentiated subsets in acute myeloid leukemia.
   Ann Hematol. 2025 May 27. doi: 10.1007/s00277-025-06418.
   PubMed         Abstract available
   
   
6. TRAN QUANG V, Cretin J, Loyaux R, Ben Jedidia B, et al
   Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia.
   Ann Hematol. 2025 May 24. doi: 10.1007/s00277-025-06417.
   PubMed         Abstract available
   
   
7. FIANCHI L, Piciocchi A, Guolo F, Marchesi F, et al
   Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study.
   Ann Hematol. 2025 May 24. doi: 10.1007/s00277-025-06381.
   PubMed         Abstract available
   
   

   
   Blood

8. EGAN G, Tasian SK
   Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A, NUP98, and GLIS2 rearrangements.
   Blood. 2025;145:2574-2586.
   PubMed         Abstract available
   
   
9. LU J, Xue SL, Wang Y, He XF, et al
   Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML.
   Blood. 2025;145:2645-2655.
   PubMed         Abstract available
   
   
10. MAYDAY MY, Biancon G, Wei M, Ramirez C, et al
    RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation.
    Blood. 2025 May 28:blood.2024027712. doi: 10.1182/blood.2024027712.
    PubMed         Abstract available
    
    
11. DE KESEL J, Fijalkowski I, Pieters T, Borin C, et al
    HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia.
    Blood. 2025 Apr 15:blood.2024026848. doi: 10.1182/blood.2024026848.
    PubMed         Abstract available
    
    
12. ESCHERICH CS, Li Z, Barnett KR, Li Y, et al
    Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin.
    Blood. 2025 May 28:blood.2024028215. doi: 10.1182/blood.2024028215.
    PubMed         Abstract available
    
    

    
    Bone Marrow Transplant

13. NAGLER A, Ferhat AT, Kayser S, Eder M, et al
    Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT.
    Bone Marrow Transplant. 2025 May 29. doi: 10.1038/s41409-025-02620.
    PubMed         Abstract available
    
    
14. MOUKALLED N, Ferhat AT, Bazarbachi A, Blaise D, et al
    Improved outcomes over time in patients aged >/=60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party.
    Bone Marrow Transplant. 2025 May 28. doi: 10.1038/s41409-025-02630.
    PubMed         Abstract available
    
    
15. ABDUL WAHID SF, Ismail NA, Md Fauzi MF, Mohd Idris MR, et al
    Clinical outcomes of a new local CD19 CAR-T cell therapy for patients with relapsed or refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma in Malaysia.
    Bone Marrow Transplant. 2025 May 27. doi: 10.1038/s41409-025-02629.
    PubMed        
    
    

    
    Cancer Lett

16. XIANG G, Zhu P, Zhang L, Yu S, et al
    Effective leukemia-to-granulocyte induction by a cocktail of RUNX1, SPI1 and CEBPE.
    Cancer Lett. 2025;626:217820.
    PubMed        
    
    

    
    Eur J Haematol

17. ALNUGHMUSH A, Alyamany R, Remberger M, Pasic I, et al
    Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis.
    Eur J Haematol. 2025 May 28. doi: 10.1111/ejh.14438.
    PubMed         Abstract available
    
    

    
    Int J Hematol

18. TAKAHASHI N, Kikushige Y, Nakamae H, Goto T, et al
    Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.
    Int J Hematol. 2025 May 26. doi: 10.1007/s12185-025-04014.
    PubMed         Abstract available
    
    
19. KONISHI H, Tachibana T, Arai S, Izumi A, et al
    Comparison of clinical outcomes between preemptive and maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Int J Hematol. 2025 May 23. doi: 10.1007/s12185-025-04009.
    PubMed         Abstract available
    
    
20. MASUDA Y, Sadato D, Toya T, Hosoda Y, et al
    Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients.
    Int J Hematol. 2025;121:820-832.
    PubMed         Abstract available
    
    

    
    Leukemia

21. ZHANG Y, Feng Z, Du J, Liu H, et al
    High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.
    Leukemia. 2025 May 28. doi: 10.1038/s41375-025-02655.
    PubMed         Abstract available
    
    
22. BOHRA A, Hassan R, Zanwar S, Jevremovic D, et al
    Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia.
    Leukemia. 2025 May 26. doi: 10.1038/s41375-025-02653.
    PubMed        
    
    

    
    PLoS One

23. LI J, Wang S
    Integrative analysis of epigenetic subtypes in acute myeloid Leukemia: A multi-center study combining machine learning for prognostic and therapeutic insights.
    PLoS One. 2025;20:e0324380.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.